On Tuesday, Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $5.89 which represents a decrease of $-0.11 or -1.83% from the prior close of $6. The stock opened at $5.97 and ...

On Friday, Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $5.7 which represents a decrease of $-0.05 or -0.87% from the prior close of $5.75. The stock opened at $5.78 and ...

Indeed, shares of RXRX stock are rocketing more than 10% higher today on some rather intriguing catalysts. Yesterday, the company made a big announcement at the J.P. Morgan Healthcare Conference.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) President and Chief Operating Officer, Tina Marriott, has executed a sale of company shares, according to a recent Form 4 filing with ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...

In the latest market close, Recursion Pharmaceuticals (RXRX) reached $6.67, with a -0.74% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.76%.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Short interest and days to cover can be used to indicate market sentiment and gauge the stock market in an investor’s analysis. Please note: If days to cover is between 0 and 1, it is rounded up ...